Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Hexima Limited
  6. News
  7. Summary
    HXL   AU0000111932

HEXIMA LIMITED

(HXL)
  Report
Delayed Australian Stock Exchange  -  07:27:23 2023-02-05 pm EST
0.0170 AUD   -5.56%
01/30Hexima Limited Declares Voting Results
CI
01/03Arovella Therapeutics Appoints COO
MT
2022Hexima Acting CEO to Step Down
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Hexima Limited Reports Earnings Results for the Full Year Ended June 30, 2021

08/27/2021 | 01:09am EST

Hexima Limited announced earnings results for the full year ended June 30, 2021. For the full year, the company announced total revenue was AUD 4.163 million compared to AUD 2.568 million a year ago. Operating loss was AUD 6.825 million compared to AUD 3.534 million a year ago. Net loss was AUD 6.873 million compared to AUD 3.625 million a year ago. Basic loss per share from continuing operations was AUD 0.0614 compared to AUD 0.0557 a year ago.


ę S&P Capital IQ 2021
All news about HEXIMA LIMITED
01/30Hexima Limited Declares Voting Results
CI
01/03Arovella Therapeutics Appoints COO
MT
2022Hexima Acting CEO to Step Down
MT
2022Nicole Van Der Weerden to Step Down as CEO of Hexima Limited
CI
2022Hexima Receives AU$6 Million Tax Incentive Refund from Australian Taxation Office
MT
2022Hexima Limited Receives Requisition Notice from Merchant Biotech Fund
CI
2022Hexima Limited Announces Board Changes
CI
202210,150,000 Options of Hexima Limited are subject to a Lock-Up Agreement Ending on 1-DEC..
CI
20226,925,878 Ordinary Shares of Hexima Limited are subject to a Lock-Up Agreement Ending o..
CI
2022Hexima : 2022 Annual Financial Report
PU
More news
Financials
Sales 2022 5,81 M 3,99 M 3,99 M
Net income 2022 -10,0 M -6,89 M -6,89 M
Net cash 2022 3,96 M 2,72 M 2,72 M
P/E ratio 2022 -0,46x
Yield 2022 -
Capitalization 2,84 M 1,98 M 1,95 M
EV / Sales 2021 4,62x
EV / Sales 2022 0,18x
Nbr of Employees -
Free-Float 51,4%
Chart HEXIMA LIMITED
Duration : Period :
Hexima Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Jonathan West Non-Executive Chairman
Marilyn Ann Anderson Chief Scientific Officer
Yolanda Gaspar Head-Clinical Operations
Scott Robertson Independent Non-Executive Director
Nicole Louise van der Weerden Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
HEXIMA LIMITED-15.00%2
MODERNA, INC.-3.55%66 559
LONZA GROUP AG21.92%44 368
IQVIA HOLDINGS INC.15.76%44 054
ALNYLAM PHARMACEUTICALS, INC.-1.80%28 711
SEAGEN INC.7.38%25 622